Syntax Advisors »

Biogen Idec shares owned by Syntax Advisors

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Syntax Advisors from 13F filings

Historical chart of Syntax Advisors investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Syntax Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Syntax Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $231k 899 257.01
2023-06-30 $211k 742 284.85
2023-03-31 $260k 935 278.03
2022-12-31 $234k 846 276.92
2022-09-30 $323k 1.2k 267.38
2022-06-30 $248k 1.2k 203.61
2022-03-31 $244k 1.2k 210.34
2021-12-31 $268k 1.1k 239.71